MedTrace Logo

AI-Powered Neonatal Risk Assessment for Improved Perinatal Outcomes

NCT07064356 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50000

Last updated 2025-07-14

No results posted yet for this study

Summary

This study aims to develop advanced artificial intelligence (AI) models that predict neonatal risks and complications based on historical multimodal health data, including ultrasound and MRI scans. The objective is to empower clinicians and provide clear, compassionate support for families navigating complex prenatal diagnoses.

Conditions

  • Congenital Anomalies
  • Neonatal Complications
  • Perinatal Outcomes
  • Perinatal Outcomes of the Mother and Fetus

Sponsors & Collaborators

  • FetalFirst Limited

    lead INDUSTRY

Principal Investigators

  • Nawal (Nina) Abide, EMBA, MA, BA · FetalFirst Limited

Eligibility

Min Age
1 Year
Max Age
1 Year
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-31
Primary Completion
2026-06-30
Completion
2026-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07064356 on ClinicalTrials.gov